Market Place
Sourcing Support
Delta-Fly Pharma Update for Expanded Phase I Study of DFP-14927
05 Nov 2024 //
BUSINESSWIRE
Delta-Fly Pharma Begins Promising AML Phase I/II Study
28 Oct 2024 //
BUSINESSWIRE
Delta-Fly Initiates DFP-10917 Phase I/II Combo-study In AML
10 Sep 2024 //
BUSINESSWIRE
Delta-Fly Pharma Initiates Phase III Trial Of DFP-14323
03 Jul 2024 //
BUSINESSWIRE
Delta-Fly Notice to Conduct the Ph I/II of DFP-10917 combined with Venetoclax
08 Apr 2024 //
BUSINESSWIRE
Delta-Fly: FDA submission of the protocol of the Phase I/II study of DFP-10917
11 Mar 2024 //
BUSINESSWIRE
Delta-Fly Pharma: Abstracts submission for Phase I Clinical Trial of DFP-14927
07 Feb 2024 //
BUSINESSWIRE
Delta-Fly Pharma Inc.: Notice of Initiation of PIII Pivotal trial of DFP-14323
02 Feb 2024 //
BUSINESSWIRE
Delta-Fly Pharma: Update on the R&D status of DFP-10917 and DFP-14927
05 Jan 2024 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.